1-3 of 3
Helen Weston
Close
Sort by
Journal Articles

Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16

Clinical Trials & Observations
Peter Mollee, John Reynolds, Wojt Janowski, Hang Quach, Philip Campbell, Simon Gibbs, Sophie Lee, Edwin Lee, Kerry Taylor, Tara Cochrane, Craig Wallington-Gates, Fiona Kwok, Nicholas Weber, Ian Kerridge, Helen Weston, P. Joy Ho, Michael Francis Leahy, Noemi Horvath, Andrew Spencer
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3721–3730.
https://doi.org/10.1182/bloodadvances.2023012539
Published: 2024
Includes: Supplemental data
Journal Articles

Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies

Clinical Trials & Observations
Sara Carrillo de Albornoz, Alisa M. Higgins, Dennis Petrie, Adam Irving, Laura Fanning, Robert Weinkove, Philip Crispin, Claire Dendle, Michael Gilbertson, Anna Johnston, Anastazia Keegan, Dominic Pepperell, Humphrey Pullon, John Reynolds, Tina van Tonder, Judith Trotman, Neil Waters, Cameron Wellard, Helen Weston, C. Orla Morrissey, Erica M. Wood, Zoe K. McQuilten
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2259–2267.
https://doi.org/10.1182/bloodadvances.2023012047
Published: 2024
Includes: Supplemental data
Journal Articles

Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy

Clinical Trials & Observations
Zoe K. McQuilten, Robert Weinkove, Le Thi Phuong Thao, Philip Crispin, Amber Degelia, Claire Dendle, Michael Gilbertson, Anna Johnston, Anastazia Keegan, Dominic Pepperell, Humphrey Pullon, John Reynolds, Tina van Tonder, Judith Trotman, Neil Waters, Cameron Wellard, Helen Weston, C. Orla Morrissey, Erica M. Wood
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1787–1795.
https://doi.org/10.1182/bloodadvances.2023011231
Published: 2024
Includes: Supplemental data